MME
AGN

Meag Munich Ergo’s Allergan plc AGN Stock Holding History

Meag Munich Ergo’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,187
Closed -$988K – 521
2019
Q4 		$988K Sell
5,187
-15,620
-75% -$2.82M 0.11% 197
2019
Q3 		$3.49M Buy
20,807
+8,537
+70% +$1.39M 0.18% 127
2019
Q2 		$2.04M Hold
12,270
– – 0.16% 145
2019
Q1 		$1.8M Sell
12,270
-4,753
-28% -$689K 0.15% 163
2018
Q4 		$2.27M Sell
17,023
-12,823
-43% -$2.1M 0.28% 98
2018
Q3 		$5.66M Buy
29,846
+4,976
+20% +$914K 0.33% 92
2018
Q2 		$4.23M Sell
24,870
-18,088
-42% -$2.9M 0.26% 131
2018
Q1 		$7.09M Buy
42,958
+26,948
+168% +$4.52M 0.29% 111
2017
Q4 		$2.65M Sell
16,010
-42,583
-73% -$7.64M 0.1% 239
2017
Q3 		$12M Sell
58,593
-7,450
-11% -$1.73M 0.49% 67
2017
Q2 		$16.1M Sell
66,043
-21,767
-25% -$5.11M 0.71% 35
2017
Q1 		$21M Buy
87,810
+74,676
+569% +$17.4M 0.83% 22
2016
Q4 		$2.74M Sell
13,134
-5,916
-31% -$1.23M 0.13% 193
2016
Q3 		$4.4M Buy
+19,050
New +$4.66M 0.22% 127

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Meag Munich Ergo's AGN Position: Q1 2020 in Review

Meag Munich Ergo sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 5,187 shares — an estimated $988K sold.

Meag Munich Ergo first reported a position in AGN in Q3 2016 and held it in 14 quarters. The position peaked at $21M in Q1 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Meag Munich Ergo reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Meag Munich Ergo sold 5,187 Allergan plc shares in Q1 2020, an estimated $988K.
  • Meag Munich Ergo first reported a position in Allergan plc in Q3 2016 and held it in 14 quarters.
  • Meag Munich Ergo's Allergan plc position peaked at $21M in Q1 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Meag Munich Ergo's 13F filing for Q1 2020, filed 23 Apr 2020.